Non-Injectable Insulin Market
According to Intent Market Research, the Non-Injectable Insulin Market is expected to grow from USD 7.5 billion in 2024-e at a CAGR of 9.5% to touch USD 12.9 billion by 2030. The Non-Injectable Insulin Market is dominated by key players such as, Eli Lilly and Co., Novo Nordisk, Boehringer Ingelheim,... Read More